GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OCSE:BAVA) » Definitions » Cyclically Adjusted PB Ratio

Bavarian Nordic A/S (OCSE:BAVA) Cyclically Adjusted PB Ratio : 2.32 (As of Jun. 09, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic A/S Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Bavarian Nordic A/S's current share price is kr180.75. Bavarian Nordic A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr77.88. Bavarian Nordic A/S's Cyclically Adjusted PB Ratio for today is 2.32.

The historical rank and industry rank for Bavarian Nordic A/S's Cyclically Adjusted PB Ratio or its related term are showing as below:

OCSE:BAVA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.81   Med: 3.49   Max: 8.59
Current: 2.32

During the past years, Bavarian Nordic A/S's highest Cyclically Adjusted PB Ratio was 8.59. The lowest was 1.81. And the median was 3.49.

OCSE:BAVA's Cyclically Adjusted PB Ratio is ranked worse than
59.15% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs OCSE:BAVA: 2.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bavarian Nordic A/S's adjusted book value per share data for the three months ended in Mar. 2024 was kr130.533. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr77.88 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bavarian Nordic A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bavarian Nordic A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Cyclically Adjusted PB Ratio Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.19 3.97 4.97 3.28 2.38

Bavarian Nordic A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.89 2.78 2.19 2.38 1.99

Competitive Comparison of Bavarian Nordic A/S's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Bavarian Nordic A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Cyclically Adjusted PB Ratio falls into.



Bavarian Nordic A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bavarian Nordic A/S's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=180.75/77.88
=2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bavarian Nordic A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=130.533/118.4000*118.4000
=130.533

Current CPI (Mar. 2024) = 118.4000.

Bavarian Nordic A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 28.022 99.700 33.278
201409 26.686 99.700 31.691
201412 35.795 99.400 42.637
201503 36.196 100.200 42.771
201506 38.364 100.300 45.287
201509 37.023 100.200 43.748
201512 37.902 99.800 44.966
201603 31.104 100.200 36.754
201606 46.293 100.600 54.484
201609 48.323 100.200 57.100
201612 50.914 100.300 60.102
201703 51.368 101.200 60.099
201706 53.397 101.200 62.472
201709 65.284 101.800 75.930
201712 61.531 101.300 71.918
201803 57.162 101.700 66.548
201806 55.195 102.300 63.882
201809 55.826 102.400 64.549
201812 53.473 102.100 62.010
201903 51.180 102.900 58.889
201906 48.622 102.900 55.946
201909 46.310 102.900 53.286
201912 45.658 102.900 52.536
202003 87.660 103.300 100.474
202006 89.840 103.200 103.072
202009 90.228 103.500 103.217
202012 83.890 103.400 96.060
202103 93.051 104.300 105.630
202106 90.873 105.000 102.470
202109 90.241 105.800 100.988
202112 104.818 106.600 116.421
202203 101.107 109.900 108.927
202206 97.808 113.600 101.941
202209 98.626 116.400 100.321
202212 101.290 115.900 103.475
202303 117.346 117.300 118.446
202306 124.547 116.400 126.687
202309 120.048 117.400 121.071
202312 132.658 116.700 134.590
202403 130.533 118.400 130.533

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bavarian Nordic A/S  (OCSE:BAVA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bavarian Nordic A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (OCSE:BAVA) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (OCSE:BAVA) Headlines

No Headlines